Overview

The webinar is part of a series of webinars, organised by the Healthcare and Life Sciences Committee that intends to capture the actual influence of the Covid-19 pandemic on the regulatory approval paths for medicine, medical devices, diagnostics and vaccines; as well as on clinical trials around the world. The speakers will also propose alternative regulatory routes that are required in order to fight the pandemic or at the least enable a routine life in this unstable period.

---